HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of sulindac on sporadic colorectal adenomatous polyps.

AbstractBACKGROUND:
Although sulindac is known to cause regression of colorectal adenomatous polyps in familial adenomatous polyposis, less is known about the effect of sulindac on sporadic adenomas. The precise mechanisms of these effects also remain to be determined.
AIMS:
Sulindac was given to patients with sporadic colorectal adenomatous polyps to evaluate its effects on them, and histological analysis was performed to elucidate the mechanism of the polyp regression, as well the kind of adenomatous polys that are susceptible to the agent.
SUBJECTS:
20 adenomatous polyps in 15 patients were studied.
METHODS:
Sulindac (300 mg daily) was given for four months, followed by colonoscopy with removal of the residual polyps. Polyp size, degree of atypia, inflammatory cell infiltration in the polyps, and immunostaining for mutant p53 product were evaluated before and after treatment.
RESULTS:
13 of the 20 polyps shrank or disappeared. Patient sex, polyp location, size, degree of atypia, or p53 mutation did not affect the response, but polyps in older patients were more sensitive to sulindac. The degree of atypia or inflammatory cell infiltration was not affected by the treatment. A polyp containing a focal cancer was unresponsive.
CONCLUSIONS:
Sulindac can cause regression of sporadic colorectal adenomatous polyps.
AuthorsN Matsuhashi, A Nakajima, Y Fukushima, Y Yazaki, T Oka
JournalGut (Gut) Vol. 40 Issue 3 Pg. 344-9 (Mar 1997) ISSN: 0017-5749 [Print] England
PMID9135523 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Tumor Suppressor Protein p53
  • Sulindac
Topics
  • Adenomatous Polyps (drug therapy, metabolism, pathology)
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Colorectal Neoplasms (drug therapy, metabolism, pathology)
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Mutation
  • Sulindac (therapeutic use)
  • Tumor Suppressor Protein p53 (analysis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: